Table 1:

Analysis of enhancement kinetics: BPA versus SCA

CategoryBPASCAP Value
Presence of uncontaminated arterial phase,a %68 ± 4768 ± 471
Peak arterial phaseb (sub)6.96 ± 1.636.15 ± 1.84.023
Peak arterial phaseb (unsub)6.96 ± 1.636.15 ± 1.84.023
Peak venous phaseb (sub)8.52 ± 1.648.0 ± 1.68.123
Peak venous phaseb (unsub)8.52 ± 1.648.0 ± 1.68.123
Peak venous–peak arterial phaseb (sub)1.56 ± 1.071.88 ± 1.19.161
Peak venous–peak arterial phaseb (unsub)1.56 ± 1.071.86 ± 1.18.186

  • Note:—All values are reported as mean ± standard deviation; sub, unsub reflect background subtracted and nonsubtracted volumes.

  • ↵a Percentage of cases with uncontaminated arteriographic phase (see text).

  • ↵b Expressed in terms of average, time-resolved phase number.